Female Pattern Hair Loss: Causes, Stages, and Treatment Options in 2026

What Is Female Pattern Hair Loss?

Female pattern hair loss (FPHL), also called androgenetic alopecia in women, is a genetically influenced, progressive condition characterised by diffuse thinning over the crown and central scalp. Unlike telogen effluvium, which causes sudden shedding in response to a stressor, FPHL develops gradually over months and years. It does not typically cause a receding frontal hairline the way male pattern baldness does. Instead, women usually retain their frontal hairline while experiencing widening of the central parting, the hallmark of female pattern baldness.

The underlying mechanism is follicular miniaturisation, a process by which hair follicles shrink progressively over repeated growth cycles, producing shorter, finer, less pigmented hairs until the follicle becomes dormant. This is driven primarily by dihydrotestosterone (DHT), a potent androgen metabolite, binding to receptors within the follicle's dermal papilla.

Hair Loss Causes in Women: What's Really Driving It

Understanding why hair falls is the prerequisite to treating it effectively. Female hair thinning causes are rarely singular; most women presenting with significant hair loss have two or more contributing factors operating simultaneously.

• Genetic predisposition: The single strongest predictor of female pattern baldness. Genetic sensitivity to DHT is inherited and cannot be changed, but it can be managed.
• Hormonal hair loss: Menopause, perimenopause, post-partum hormonal changes, and PCOS hair loss all alter the androgen-oestrogen balance, accelerating androgenic alopecia in susceptible women. Falling oestrogen levels reduce the natural protective buffer against DHT activity at the follicle.
• Iron & nutritional deficiency: Iron deficiency hair loss is one of the most common and most reversible causes of hair thinning in women. Ferritin below 70 ng/mL meaningfully impairs the hair growth cycle. B12, vitamin D, and zinc deficiencies are also established causes of heavy hair fall in female patients.
• Stress-induced shedding (telogen effluvium): A physiological or emotional shock, illness, surgery, crash dieting, or bereavement can push a large proportion of follicles prematurely into the resting phase, causing widespread shedding 6–12 weeks later.
• Thyroid dysfunction: Both hypothyroidism and hyperthyroidism disrupt the hair growth cycle. Thyroid-related hair fall causes are typically diffuse and correctable once the underlying imbalance is addressed medically.
• Medications & medical conditions: Certain contraceptives, antidepressants, blood pressure medications, and chemotherapy agents are established causes of hair loss in women. Always review your medication list with a dermatologist when assessing excessive hair fall.

Telogen Effluvium vs. Androgenetic Alopecia: Know the Difference

• Telogen effluvium is defined by sudden, diffuse shedding often alarming in volume, triggered by a clear stressor event. Hair sheds uniformly across the scalp rather than in a patterned distribution. Most cases resolve within 3–6 months once the trigger is removed.
• Androgenetic alopecia, including diffuse alopecia in women, is chronic, progressive, and patterned. There is no single trigger event; it develops across years. Left untreated, it advances through identifiable stages.

Both conditions can and frequently do occur simultaneously, which is why accurate clinical diagnosis should precede any treatment decision.

Stages of Female Pattern Baldness: The Ludwig Scale

Clinicians use the Ludwig scale, the primary grading tool for female pattern hair loss, to classify severity and guide treatment decisions. Unlike the Norwood scale used for male pattern baldness stages, the Ludwig scale accounts for the diffuse, crown-centred pattern typical in women.

A dermatologist may also use the Savin scale, which includes a density scoring component, or dermoscopy to directly assess the degree of follicular miniaturisation often detectable before visible thinning is apparent.

Hair Loss Treatment for Women in 2026: Full Spectrum

There is no single best hair loss treatment for females—the right protocol depends on the type of alopecia, stage, hormonal profile, and individual health history.

Topical & Oral Pharmacology

1. Minoxidil (topical 2%/5% or oral low-dose): The only FDA-approved topical for female pattern hair loss treatment. It prolongs the anagen phase and increases follicular size. Effects reverse if discontinued.
2. Spironolactone: An anti-androgen that blocks DHT at the receptor level. Widely used in hormonal hair loss and PCOS hair loss treatment. Contraindicated in pregnancy.
3. Finasteride / Dutasteride: 5-alpha reductase inhibitors that reduce systemic DHT production. Used off-label in post-menopausal women as androgenic alopecia treatment and remain under specialist management.
4. Iron & nutritional correction: An essential first step when deficiency is confirmed. Ferritin, B12, vitamin D, and zinc should be assessed and corrected before layering additional interventions.

PRP (Platelet-Rich Plasma)

PRP draws growth factors from the patient's own blood and injects them into the scalp. It remains a widely used hair growth treatment for women, but results are highly variable, dependent on platelet concentration, preparation protocol, and individual response.

Hair Transplant Surgery

Surgical restoration is appropriate only for women with stable, patterned loss and a healthy, non-miniaturised donor zone at the occipital scalp. Specialist assessment is essential before pursuing this route.

How to Stop Hair Thinning

For women asking how to stop hair thinning or how to regrow thinning hair, the most important first step is accurate diagnosis. A trichologist or dermatologist can:

• Run targeted blood panels: ferritin, thyroid function, androgens, B12, and vitamin D.
• Perform scalp dermoscopy to assess follicular miniaturisation directly.
• Distinguish between the overlapping types of hair loss driving a specific presentation.

Treatment initiated before follicles are permanently lost consistently produces better, more durable outcomes. Early-stage FPHL is far more responsive to both topical and regenerative intervention than advanced loss.

The Bottom Line

Female pattern hair loss is common, progressive, and—when identified early—very treatable. Understanding the specific type of hair loss, staging it accurately on the Ludwig scale, and selecting treatments that address the underlying mechanism rather than just symptoms is what separates meaningful recovery from temporary management.

Frequently Asked Questions